 "Mohit Malhotra")
The pandemic may have disrupted Dabur’s business initially, but the firm recovered quickly to post healthy double-digit growth in the past four quarters. Mohit Malhotra, chief executive officer of Dabur India, tells Arnab Dutta in an interview that a steep rise in prices, changing consumer preference, and a dynamic business environment are keeping him on his toes. Edited excerpts:
What are the key changes in consumer preference?
Covid-19 has made ayurveda a mainstream category and I believe this will continue even after the pandemic. We have a large portfolio of ayurvedic medicines and immunity boosting products. Demand for products like chawanprash and
